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1. Introduction 
Milk fat globule membrane (MFGM) is a protein-lipid biopolymer that originates from the 
apical surface of mammary epithelial cells and surrounds fat globules in milk. During milk 
synthesis, fat droplets originate in the endoplasmic reticulum and travel directly to the cell’s 
apical surface. As they travel from the epithelial cells into the alveolar lumen, they pass 
through the apical membrane and are encapsulated in the plasma membrane complete with 
the exterior glycocalyx resulting in discrete globules. These milk fat globules have a 
nonpolar lipid core composed primarily of triglycerides that is surrounded by the MFGM 
which contains both membrane polar lipids and glycoproteins. 
While MFGM is in all dairy products containing milk fat, it is especially enriched in churn 
buttermilk, a co product of butter production. When milk fat is churned, the membrane 
surrounding the fat globules is disrupted, and the free fat released from the globules 
coalesces. This process ultimately results in a solid fat phase, butter, and an aqueous phase, 
also known as churn buttermilk. This material, buttermilk, has a long history of anecdotal 
health-promoting associations, yet it does not currently generate any added value in the 
market place for delivering nutritional benefit. MFGM has recently been shown in lipidomic 
and proteomic characterizations to have an interesting carbohydrate, lipid and protein 
profile.  The phospholipids and membrane glycoproteins found in MFGM likely interact 
extensively with the gut epithelia during digestion, both physically and biochemically. 
Moreover, MFGM has a relatively high concentration of sphingolipids, which in purified 
form have been demonstrated to be protective against colon cancer. 
The unique composition of MFGM has led to the idea that it may have remarkable 
nutraceutical properties, however, few studies have tested this hypothesis.  Recent studies 
from our laboratory have demonstrated that dietary MFGM improves gut barrier function 
in cell and animal models and is protective against colon cancer in a rodent model.  In this 
chapter we will discuss the isolation, composition, biochemical properties and intestinal 
health promoting effects of the biopolymer MFGM. 
1.1 Milk fat globule membrane 
The role of milk in biology is to nourish infant mammals and to provide vigor, while not 
overtaxing the biosynthetic capacity of the mother. This functionality has been refined and 
developed over time via evolutionary selective pressure. Like much of molecular evolution, 
components of mammalian milks have been repurposed from other functions in biology, 
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and the rationale for this is often not clear. While the nutritive value of milk has long been 
recognized from a compositional perspective, research into the nutritional functionality of 
milk components has consistently revealed novel pleiotropic beneficial effects which go 
beyond simple nutrient content (2002; Ward and German 2004; Ward et al. 2004). As 
unnecessary components would likely be selected against over time, it is hard to imagine 
there is much that is in milk that would not be interesting from a nutritional perspective. For 
example, while casein and whey proteins are each recognized as good sources of essential 
amino acids, current studies are finding novel peptides, which are produced during 
digestion of these proteins, which positively affect health beyond delivery of amino acids. 
One interesting, yet underappreciated dairy-derived ingredient is the milk fat globular 
membrane. Milk fat has a complex native structure which is the result of a novel synthesis 
and secretion process (reviewed in (Ward, German, and Corredig 2005)). Milk triglycerides 
are synthesized and/or assembled in the endoplasmic reticulum (ER) of the lactating 
epithelial cell, and after budding off, are transported to the apical surface of the cell 
complete with a monolayer of polar lipids derived from the ER. As the fat droplets reach the 
surface of the cell they pass through the apical membrane and in the process are coated in a 
bilayer of cell surface membrane. The result of this process is that all native milk fat droplets 
contain 3 layers of polar membrane lipids, and the surface of the droplets has the molecular 
characteristics of epithelia. In human, bovine, caprine and ovine milks (the only ones 
reported), fat globules are present in a bimodal distribution with the diameter of the small 
globules centered at roughly 0.4 μm and the larger at about 3μm (Figure 1). Based on this 
size distribution, Ruegg and Blanc have estimated that there is up to 500cm2 of membrane 
surface area in one ml of milk (Ruegg and Blanc 1981). A scanning electron micrograph of 
native milk fat globules (left) and MFGM recovered from buttermilk via ultrafiltration 
(right) is shown Figure 2. Because each fat globule is enrobed in a coating of apical 
membrane from the lactating epithelial cell, the outside surface is covered in glycocalyx. 
Interestingly, when this material is removed from the fat globules, it may be recovered in a 
form which appears to be an empty sac of membrane. A scanning electron micrograph of 
MFGM isolated via an ultrafiltration process is shown on the right side of Figure 2.  
 
 
Fig. 1. Distribution of milk fat droplets by volume (left) and number (right) measured with 
laser diffraction particle size analyzer. The majority of the fat in milk is present in the large 
fat droplets (left), while the majority of the droplets are less than 1 µm in diameter (right).  
When milk fat is churned, as in the production of butter, the membrane surrounding the fat 
globules is disrupted and free fat released from the globules coalesces. This process 
ultimately results in a solid fat phase (butter) and an aqueous phase, also known as churn 
buttermilk. This material (buttermilk) has a long history of anecdotal health-promoting 
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associations, yet it does not currently generate any added value in the market place for 
delivering nutritional benefit. As large quantities are produced in the US annually, and as it 
gets spray dried and used as an ingredient in many products, it seems worthy of 
investigating potential benefits its consumption might confer. In November of 2008, 7.2 M 
lbs of (dried) buttermilk were produced in the US (http://www.ams.usda.gov). As 
approximately 8% of buttermilk is MFGM (Astaire et al. 2003), annual production of this 
material is estimated to be roughly 7 M lbs. 
 
 
Fig. 2. Scanning electron micrographs of native milk fat globules (left) and milk fat globular 
membrane isolated from buttermilk with ultrafiltration (right). 
2. MFGM composition 
As a result of the synthetic process that produces it, MFGM has an interesting profile of 
carbohydrates, lipids and proteins. The main lipid and protein constituents are listed in 
Table 1 and were, for the most part, discovered and characterized using basic protein and 
lipid analysis techniques. While this list of lipids is in the table is fairly comprehensive, the 
proteins listed are the main components that have been studied using one dimensional gel 
electrophoresis which is not particularly sensitive.  However, recently several groups have 
begun to detect many more proteins present at trace levels using proteomics techniques.  
For example, Reinhart and Lippolis (2006) detected up to 120 proteins using a combination 
of one dimensional SDS gel electrophoresis and micro-capillary HPLC nanospray-tandem 
mass spectrometry of tryptic digests from the gel. Of the proteins detected, 71% were 
membrane associated and the balance were identifies as either cytoplasmic proteins or 
secreted proteins. The molecular function of the proteins identifies were membrane/protein 
trafficking (23%) cell signaling (23%), unclassified (21%), fat metabolism/transport (9%), 
protein synthesis/folding (7%), immune proteins 4%) and milk proteins (2%). Fong et al 
(2007) investigated both protein and lipid constituents of the MFGM using mass 
spectrometry. In this study, eight novel proteins were detected in the MFGM and a more 
complete analysis of the lipid fraction was reported. A third group used direct liquid 
chromatography-tandem mass spectrometry (LC-MS) and 2D gel electrophoresis followed 
by matrix assisted laser desorption ionization-time-of-flight mass spectrometry (MALDI-
TOF) of individual protein gel spots to characterize minor proteins (Smolenski et al. 2007). 
www.intechopen.com
  
Biotechnology of Biopolymers 
 
324 
In total, they identified 95 distinct gene products at least 15 of which were involved in host 
defense.  
 
Lipids % Polar lipids % Proteins 
Triacylglycerols 62 Sphingomyelin 22 Mucin 1 
Diacylglycerols 9 Phosphatidylcholine 36 Xanthine oxidoreductase 
Monoacylglycerols Trace Phosphatidylethanolamine 27 PAS III 
Sterols 0.2-2 Phosphatidylinositol 11 CD 36 
Sterol esters 0.1-0.3 Phosphatidylserine 4 Butyrophilin 
Free Fatty acids 0.6-6 Lysophosphatidylcholine 2 PAS 6/7 
Hydrocarbons 1.2   Adipophilin 
Phospholipids 26-31   Fatty acid binding protein 
Table 1. Major Components of MFGM (Adapted from (Keenan and Patton 1995)) 
In these initial studies, the analyses were all qualitative and no attempt was made to 
quantify specific proteins. Recently, Fong and Norris (2009) utilized the absolute 
quantification (AQUA) technique, a proteomic to explore the abundance of specific MFGM 
proteins. In their analysis, six proteins (fatty acid binding protein, butyrophilin, PAS 6/7, 
adipophilin, xanthine oxidase and mucin 1) were measured and have all been long known 
to be components of MFGM (Table 1). Although their absolute results appear to depend 
somewhat on how the material was isolated, the relationship among the major proteins 
appears to be stable. According to their results, the amount of these proteins are present in 
the membrane in decreasing order PAS 6/7, butyrophilin, xanthine oxidase, mucin 1, 
adipophilin, and fatty acid binding protein.  In a somewhat related study, Affolter et al 
(2010) compared proteomic profiles of a whey protein isolate with buttermilk powder. 
Using a shotgun proteomics approach, they identified 244 proteins in the whey powder and 
133 in the buttermilk isolate. In addition, they conducted a relative quantitative comparison 
of the top 34 proteins identified.  
While most studies of MFGM proteins have focused on membranes isolated from either 
human or bovine milk, recently analyses of both goat and sheep MFGM have been reported. 
Cebo et al (2010) used one dimensional SDS-PAGE to investigate goat MFGM. In their 
analyses using peptide mass fingerprinting of proteins from the electrophoresis gel they 
detected many of the same proteins listed in Table 1 (mucin 1, xanthine oxidase 
butyrophilin, lactadherin and adipophilin). As for analysis of MFGM isolated from sheep 
milk, Pisanu et al (2011) used SDS-PAGE combines with tandem LC-MS to characterize the 
protein content of this biopolymer. In their analysis, 140 unique proteins were identified and 
their relative abundance measured. Of the components detected, gene ontology classifiers 
indicated that the majority were associated with membrane and vesicular trafficking (~35%), 
protein synthesis, binding and folding (~15%), enzymatic activity (~15%) and cell signaling 
(~12%). Other minor activities mediated by these proteins  were immune function (~8%) 
and fat transport/metabolism (~7%). The most abundant proteins were butyrophilin, 
xanthine oxidase, lactadherin and adipophilin.  
3. Isolation of MFGM  
MFGM is a minor component of milk fat and in most dairy products. However, in modern 
dairy operations it is produced as a byproduct in preparation of both cheese and butter. 
www.intechopen.com
 Nutraceutical Properties of Milk Fat Globular Membrane 
 
325 
Nevertheless, to obtain it in a relatively concentrated form it must be separated from other 
components. Isolation of MFGM may be conducted on a lab scale for detailed anayses 
and/or functional characterization. In addition, in recent years several groups have 
published methods for isolation of MFGM from byproducts such as cheese whey and churn 
buttermilk. In work conducted in our laboratories MFGM is isolated using a combination of 
casein precipitation and ultrafiltration. The process begins with raw milk and cream is 
collected via centrifugation. The cream is churned in a Waring Blender for 30 minutes at 
4°C. The resulting butter is removed from the buttermilk using filtration through cheese 
cloth to remove butter particles. To precipitate caseins in the buttermilk the pH is lowered to 
4.6 using acetic acid and the temperature raised to 37 °C for 30 minutes with constant 
stirring. Precipitated caseins are removed via centrifugation at 1000 × g for 30 min.  The pH 
is readjusted to 6.7 with 1M NaOH, and the buttermilk is ultrafiltered with a Millipore 
Prep/Scale benchtop unit using a MWCO filter of 300kD. The buttermilk is diafiltered for 
several hours at 4°C, until 6 volumes of the starting material are collected as permeate. The 
retained material, or retentate, issubsequently freeze dried.  
In the past several years several groups have developed methods to isolate MFGM from 
both cheese whey and buttermilk. Astaire et al (2003) used a two step process to produce a 
MFGM isolate enriched in phospholipids. In the first step MFGM was subjected to 
microfiltration with a 0.8 micron pore size filter. To remove nonpolar lipids the resulting 
material was then subjected to supercritical fluid extraction. One drawback of isolating 
MFGM from buttermilk with microfiltration is that casein micelles are also retained in the 
process. Corredig et al  (2003) addressed this problem by adding sodium citrate to the 
process, which facilitates the dissolution of the micelles and their removal in the permeate. 
Other groups have shown that MFGM may also be isolated from other dairy products, such 
as butter serum. For example, Rombaut et al (2006) used microfiltration with both sodium 
citrate and ethanol additions to facilitate the removal of casein micelles and reported 
obtaining a relatively pure product. This group has also demonstrated that a similar process 
is effective for recovering MFGM from acid buttermilk cheese whey (Rombaut, 
Dejonckheere, and Dewettinck 2007). In an improvement on this process, it was found that 
increased recoveries of MFGM can be achieved via a process termed thermocalcic 
aggregation (Rombaut and Dewettinck 2007). This process utilizes pH adjustments as well 
as heat and added calcium to facilitate the precipitation of MFGM aggregates. More 
recently, Damodaran (2010) showed that zinc is a more effective divalent cation than ether 
magnesium or calcium in causing MFGM components to aggregate.  
4. Interactions of MFGM with microbiota 
The large surface area of MFGM and its glycocalyx exterior suggests there may some 
interaction with the human microbiota and several studies have focused on this interaction. 
For example, Clare et al (2008) utilized an in vitro screening assay to test for antimicrobial 
activity of intact MFGM and peptide hydrolysates against several human pathogens and 
commensal bacteria. Interestingly, they found there was some activity against Salmonella 
enteric Typhimurium and Pseudomonas fluorescens that the results were variable depending on 
the growth media selected. They attributed these differential results to the presence of 
purines in the active media, which can be used by the xanthine oxidase of MFGM to 
generate peroxide. Other studies have focused on the interaction of microbes with the 
surface of MFGM. For example, Brisson et al (2010) characterized the relationship between 
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Lactobacillus reuteri and the surface of MFGM. According to their study, binding of L. 
reuteri to the surface of MFGM was dependent on the hydrophobicity of the bacteria and 
was correlated with a cell surface protein. In addition, this study involved determining 
binding force measurements which were generated with optical tweezers. Other studies 
have investigated the effects of dietary MFGM on the colonic microbiota. For example, the 
ability of MFGM to inhibit intestinal β-glucuronidase activity was measured by Ito et al. 
(1993). This enzyme is a product of colonic enterobacteria, and when present in the colon 
has the ability to activate carcinogenic precursors into carcinogens (Simon and Gorbach, 
1984). However, this activity is inhibited by sialoglycoproteins from porcine salivary glands 
(Sakamoto, 1975). To test the hypothesis that sialoglycoproteins from bovine milk might 
provide this benefit, Ito et al. (1993) conducted in vitro enzymatic assays and in vivo feeding 
studies with mice. In the enzyme assay, 0.2% w/v MFGM inhibited β-glucuronidase activity 
on the substrate p-phenolphthalein β-D-glucuronide by 90%, while κ-casein at the same 
concentration inhibited the reaction by 35%. To determine whether this activity would 
survive gastrointestinal transit, the authors fed mice diets supplemented with 5%, 10%, and 
20% MFGM for five days, and measured β-glucuronidase activity in feces. The 5% and 10% 
diets caused roughly a 15-20% inhibition of fecal β-glucuronidase activity, whereas the effect 
rose to 50% when 20% MFGM was added to the standard diet. 
5. In-Vitro studies conducted with MFGM 
5.1 In vitro MFGM digestions 
One model in which to study the bioactivities of MFGM is with cells in culture. However, 
treating cultured cells with a complex material isolated from milk is not necessarily 
physiologically relevant, and pursuing the effects of the digestion process on the integrity of 
MFGM components is warranted. Using a method adapted from Adkins and Lonnerdal, in 
vitro proteolysis of MFGM was conducted by incubating the material with porcine pepsin 
for 30 minutes at a pH of 3, and then raising the pH to 7 and continuing the process with 
porcine pancreatin (Adkins and Lonnerdal 2003). To characterize the effects of the 
proteolysis, aliquots of the digestion process were seperated using SDS-PAGE with 4-20% 
gels, stained the proteins with silver reagent (results not shown). Based on the peptide 
migration patterns in the gels from before and after digestion, very little of the native 
proteins escape digestion by gut proteases.  
While the porcine pancreatin used in the proteolysis experiment also contains pancreatic 
lipase, there is no commercial source for gastric lipase. However, von Ebner glands of rat 
tongues are a rich source, and this enzyme was isolated according to the method of Hamosh 
(Hamosh, Ganot, and Hamosh 1979). Lipolytic activity was confirmed using para-
nitrophenyl palmitate (Gupta, Rathi, and Gupta 2002). MFGM was adjusted to a pH of 3.0 
with phosphate buffer, and crude isolate of rat tongues was added. The reaction was 
allowed to proceed for 30 minutes, the pH was raised to 7.0, and pancreatin was added 
along with CaCl2 and bile salts according to the method of Bernback (Bernback, Blackberg, 
and Hernell 1990). The reaction was allowed to proceed for 1 hour and then terminated by 
submerging the sample in a 90°C water bath for 30 minutes. Samples were freeze dried, 
lipids extracted by the method of Folch (Folch, Lees, and Sloane Stanley 1957), and 
separated using thin layer chromatography. Lipids were visualized by spraying plates with 
cupric sulfate, and heating to 180 °C for 20 minutes.  
It is clear in left side of Figure 3 that the lipase treatment of MFGM causes significant 
degradation of the polar lipids, and the majority of this activity was mediated by the 
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pancreatin digestion. In addition, on the right side of the figure a second separation of lipid 
classes (triglycerides, diglycerides, monoglycerides cholesterol esters, free fatty acids and 
phospholipids) indicated that the majority of triglycerides were degraded as well. Of 
significant interest are the two boxes superimposed over Lane 4. The lower box is consistent 
with the mobility of lysophospholipids using this solvent system, whereas the top band is 
probably phosphatidic acid. Both of these species have demonstrated bioactivity. One other 
interesting feature of these results is that the sphingolipids do not appear to be affected by 
the digestion process. 
 
PE
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1            2             3             4              5     6
C            GL         PL
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Fig. 3. Results of lipolysis experiment indicate in vitro treatment of MFGM with lipases 
causes significant digestion of the polar lipids (left) and lipid clases (right). Lipids were 
isolated by chloroform:methanol extraction, and separated using thin layer 
chromatography. Lane designations (left): 1) phophatidylcholine (PC) and 
phosphatidylethanolamine (PE) standards, 2) MFGM, 3) MFGM treated with gastric lipase 
(GL), 4) MFGM treated with GL then pancreatic lipase (PL), 5) phosphatidyl serine standard, 
6) sphingomyelin standard. Boxes in Lane 4 are consistent with lipolytic generation of 
lysophospholipids (bottom) and phosphatidic acid (top). Lane designations (right): A) 
diglyceride (DAG) standard, B) MFGM, C) MFGM treated with GL, C) MFGM treated with 
GL than PL, E) Free fatty acid standard (FFA) and F) phospolipid standard. It is clear from 
Lane H that triglycerides and significantly degraded into free fatty acids, and a new band 
appears above the phospholipids which, based on mobility, is likely lysophospholipids.  
5.2 Studies in cell culture 
To understand the interaction of MFGM with the gut epithelia during digestion, studies 
with cultured epithelial cells have been used to characterize this relationship.  
Consequently, studies with cultured epithelial cells are an interesting system in which to 
characterize molecular events resulting from the interaction between MFGM and the gut. To 
probe this interaction, we have developed methods to isolate MFGM, to subject it to an in 
vitro digestion as well as to use it as a treatment for the epithelial cells.  
To investigate potential bioactive effects of the MFGM on gut integrity genome wide 
expression analysis was conducted using the Caco-2 model of cultured epithelial cells. 
MFGM was added to culture media at 1 mg/ml which was calculated to mimic the 
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concentration in milk. MFGM was reconstituted in culture media and confluent cells were 
treated for 24 hours.  mRNA was isolated and cleaned up with a commercial kit, and 
analyzed using the Illumina whole genome gene expression system with the human-6 v2 
chip which was conducted by Genome Quebec.  Gene expression of MFGM treated cells was 
compared to controls cells (no MFGM). Triplicate samples were run for both MFGM 
treatment and controls.  
Data was analyzed using Flex Array, a proprietary software program developed by Genome 
Quebec. All replicates were normalized, and several statistical programs were run to 
determine genes that were differentially expressed in response to MFGM (Empirical Bayes, 
Significance Analysis of Microarrays, 2 sample Bayes algorithm).  Surprisingly, of the 
roughly 47,000 features on the array, very few genes were differentially regulated using the 
limits of a 2 fold change and a significance level of p<0.05, and agreement was good 
between algorithms. The majority of the genes identified were metallothioneins (MT), which 
code for small molecular weight, cystein-rich proteins with redox and metal binding 
activities.  MTs are induced in the liver by a range of metals, and in the gut and pancreas 
they respond to zinc status (Coyle et al. 2002).  
MTs are thought to confer protection from heavy metal exposure and oxidative damage, 
and the coordinate expression of several isoforms in our cell system raised the possibility 
that MFGM treatment of the cells may have led to toxic exposure of heavy metals, or 
perhaps may have induced oxidative stress. Alternatively, we hypothesized that MFGM 
may be rich in zinc, and that induction of MT genes was part of mechanisms by which this 
metal is delivered in milk. In support of the oxidative stress hypothesis, one of the main 
MFGM proteins, xanthine oxidoreductase (XOR) can catalyze the formation of reactive 
oxygen (ROS) and nitrogen species (RNS), and is thought to be part of the innate immune 
system (Vorbach, Capecchi, and Penninger 2006). Perhaps not surprisingly, XOR has been 
implicated as a pathological factor in gut damage induced by ischemia/reperfusion injury 
via the generation of ROS and RNS (Blikslager, Roberts, and Argenzio 1999).  
These findings compelled us to determine the metal composition of the MFGM we isolated. 
To achieve this end, 200 mg of MFGM was wet ashed by successive digestion with nitric 
acid and hydrogen peroxide and analyzed in a Thermo Electron Iris Advantage Inductively-
coupled plasma (ICP) spectrophotometer in a Utah State core analytical facility. Trace metals 
which were above the detection limit are listed in Table 2. From the results we have 
concluded that MTs are probably not induced by heavy metal contaminants of MFGM, 
which left the possibility the effect was due to oxidative stress or due the relatively high 
concentration of zinc. As we moved forward, we kept in mind these two possibilities, as is 
discussed below. 
 
metal Ca Co Cu Mg Ni Zn 
Ppm 880 9 25 246 10 126 
Table 2. Results of trace metal analysis of MFGM using ICP  
Treatment of Caco-2 cells with digested MFGM resulted in the differential regulation of only 
62 genes using the limits of a 2-fold change and a significance level of p<0.05. Similar to the 
treatment with the native MFGM, several MT genes were upregulated, although not as 
highly. In addition, genes coding for several other zinc binding proteins were induced.  
To gain insight into the major cellular processes affected by MFGM treatment, an online tool 
for pathway analysis of microarray data 
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(http://www.pantherdb.org/tools/genexAnalysis.jsp) was utilized. This tool uses gene 
expression data to indicate whole sets of genes whose regulation would be predicted to be 
affected by the treatment, and generates statistical p-values indicating the likelihood the 
effect is due to chance. The results of the pathway analysis with the digested MFGM are 
listed in Table 3. According to the analysis, several pathways appear to be affected by the 
treatment, and the majority are downregulated. Two interesting pathways affected, in 
terms of our data, are those involved in histamine and angiotension signaling. The former 
would suggest the treatment is associated with a reduction in inflammation and the latter 
with increased blood flow. While these preliminary observations support our overall 
hypothesis, we have noted some seeming contradictions. For example, some 
proinflammatory pathways seem to be downregulated while others are upregulated by 
treatment with MFGM.  Nonetheless, due to the large volume of data generated in such 
studies, analysis is ongoing. Because this data was generated from cultured enterocytes 
the data must be interpreted with caution; therefore we are eager to adapt this model to 
whole animals.   
 
Pathway 
Number
of genes
Change P-value 
Histamine H1 receptor mediated signaling pathway 42 - 2.20E-03 
Ubiquitin proteasome pathway 80 + 4.13E-03 
Blood coagulation 60 - 4.27E-03 
Thyrotropin-releasing hormone receptor signaling pathway 64 - 4.62E-03 
5HT4 type receptor mediated signaling pathway 35 - 6.98E-03 
5HT2 type receptor mediated signaling pathway 71 - 1.07E-02 
Endogenous_cannabinoid_signaling 26 - 1.09E-02 
Alpha adrenergic receptor signaling pathway 31 - 1.15E-02 
Proline biosynthesis 4 - 1.36E-02 
Huntington disease 158 - 1.40E-02 
Angiotensin II-stimulated signaling through  
G proteins and beta-arrestin 
54 - 1.87E-02 
Beta3 adrenergic receptor signaling pathway 29 - 1.99E-02 
Table 3. Biological pathways predicted to be significantly affected in Caco-2 cells by MFGM 
subjected to an in vitro digestion process as determined by the free software tool, Panther 
(Clark et al. 2003). Pathways that are upregulated by treatment are marked with a (+)and 
those downregulated with a (-). 
5.3 Effects of MFGM on membrane permeability 
Based on the large membrane surface area in milk provided by the MFGM, we hypothesized 
that this material may have positive effects on the gut epithelia. To test this hypothesis, we 
conducted a barrier permeability assay with Caco-2 cells. Caco-2 cells were seeded on 
Corning Transwell membranes inserts (0.4 µM pore size) and placed in 6-well plates 
creating a bi-cameral chamber. Caco-2 cells were grown for 21 days on membrane inserts to 
ensure polarization and formation of tight junctions. Culture media was changed every 3 
days. As our proteolysis and lipolysis results indicated that MFGM is substantially 
degraded by the digestion process, we compared the effect of treating cells with material 
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resulting from this process, as well as native material.  To test the effects of MFGM on 
membrane integrity, cells were incubated with either: control, 1 mg/ml MFGM, 1 mg/ml 
proteolyzed MFGM or 1 mg/ml lypolozized MFGM for 24 hours.  After treatment, the 
media was changed and mucosal barrier integrity was stressed by the addition of 2 mM 
EGTA, which has been shown in previous studies to reduce the integrity of tight junctions 
(Prosser et al. 2004). To determine Caco-2 membrane integrity we measured the flux of 
phenol red from the upper chamber to the lower chamber which contained media without 
phenol red.  At 2.5 hours, 50 µl of media was sampled from the lower chamber and the 
phenol red concentration was determined by spectroscopy using the method of (Jovov, 
WIlls, and Lewis 1991). Our results, shown in Figure 4, indicate that MFGM reduced 
permeability in the control (no EGTA) as well as the treated cells. Furthermore, this effect 
was amplified when the MFGM was previously subjected to the in vitro digestion process 
described above.  
 
 
Fig. 4. Results of membrane permeability study. Caco-2 cells were grown to polarization, 
and treated with either: control (no MFGM), 1 mg/ml MFGM, 1 mg/ml proteolyzed MFGM 
(P-MFGM), or 1 mg/ml lipolyzed (MFGM) for 24 hours.  After treatment, media was 
changed and a cohort of cells were stressed by the addition 2 mM EGTA (a known stressor 
of barrier integrity) for 2 hours. Media in the upper chamber contained phenol red, whereas 
the media in the lower chamber did not. The y-axis represents phenol red concentration, 
which is indicative of membrane leakiness. It is clear that application of EGTA to the control 
cells increases permeability, and MFGM treatment reduces this effect. Interestingly, protease 
and lipase treated MFGM reduces permeability to a greater extent. Differently letter 
columns are statistically different (p<0.05.)  
5.4 Summary 
To summarize our cell culture work, we have demonstrated that MFGM treatment of 
Caco-2 cells results in a very specific induction of MT genes. This effect may be due to the 
zinc concentration (or perhaps Cu or Mn), or perhaps due to the activity of XOR in 
generating ROS and/or RNS. We have subsequently showed that MFGM is substantially 
degraded by the digestion process, and that the products of these processes appear to be 
more efficacious in promoting mucosal integrity in the Caco-2 cell model than native, 
untreated MFGM. 
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6. MFGM and colon cancer 
Colon cancer is the third most commonly diagnosed cancer in the United States and the 
second most common cause of cancer-related deaths (Society 2009). Diet is a well recognized 
contributing factor to the etiology of cancer and may be associated with 35–70% of the 
incidence of colon cancer (Doll and Peto 1981). Although various carcinogens are present in 
foods, their effects may be minor when compared with dietary components that inhibit the 
cancer process (Doll and Peto 1981).  As a consequence, many dietary treatments have been 
tested specifically for their ability to inhibit colon cancer. 
Previous studies have demonstrated that purified sphingolipids, such as sphingomyelin, are 
protective against colon cancer in animal models (Duan and Nilsson 2009; El Alwani et al. 
2006).  Sphingolipids are composed of a ceramide core, which in turn, is composed of a 
sphingosine backbone with a fatty acid covalently bonded via an amide linkage.  Several 
different head groups may be covalently attached to the ceramide, each resulting in a 
different class of sphingolipid.  Examples include sphingomyelin, with a phosphocholine 
headgroup, glycosphingolipids with one or more monosaccharides in the headgroup and 
gangliosides, which have at least three sugars in head group including at least one sialic 
acid.  The anticancer activity of sphingolipids is primarily associated with their metabolites, 
ceramide and sphingosine (Jayadev, Linardic, and Hannun 1994).  Ceramide is an important 
second messenger implicated in various physiological functions, like apoptosis, and has 
recently been associated with targeting mitochondrial activity in colon cancer cells (Dahm et 
al. 2008; Dindo et al. 2006).  Sphingolipid digestion is slow and occurs along the entire 
length of both the small intestine and the colon which results in high levels of ceramide and 
sphingosine in the lumen producing the potentially beneficial effects (Nilsson and Duan 
2006).  Dietary sphingomyelin and glycosphingolipids isolated from milk have been shown 
to inhibit chemically induced colon cancer in a mouse model (Dillehay et al. 1994; Schmelz 
et al. 2000), and administration either before or after tumor initiation reduced tumor 
formation (Lemonnier et al. 2003). 
One significant source of dietary sphingolipids is the milk fat globule membrane (MFGM), a 
protein-lipid complex that is derived from the apical surface of mammary epithelial cells 
and surrounds the fat globules in milk.  Milk fat globules are composed of a nonpolar lipid 
core (mainly triglycerides) surrounded by the MFGM, which is composed of phospholipids 
and membrane glycoproteins (see Table 1 for major components of MFGM).  Triglycerides 
are the dominant lipid class, and account for approximately 98% of milk fat, while the 
balance is composed of phospholipids (0.8%), diglycerides (0.3%), monoglycerides (0.03%), 
cholesterol (0.3%), and free fatty acids (0.1%) (MacGibbon and Taylor 2006). 
Because of its unique lipid profile, relative sphingolipid enrichment and widespread 
availability, MFGM is a good candidate for a colon chemopreventive, bioactive ingredient.  
MFGM has an interesting profile of carbohydrates, lipids and proteins, and is the most 
diverse fraction of milk.  The unique compositional feature has led to the suggestion that 
MFGM may have interesting nutraceutical properties (Spitsberg 2005), and several research 
groups have conducted studies to facilitate its recovery from buttermilk (Astaire et al. 2003; 
Corredig, Roesch, and Dalgleish 2003; Morin et al. 2007; Morin, Pouliot, and Jimenez-Flores 
2006; Rombaut, Dejonckheere, and Dewettinck 2006, 2007; Rombaut and Dewettinck 2007; 
Spence et al. 2009, 2009) 
6.1 Experimental design 
Although very few studies have been conducted to determine any nutritional benefits of 
MFGM, some indicate positive effects.  A recent study concluded digestion products of 
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MFGM may have antimicrobial activity (Clare et al. 2008). Because of its unique biochemical 
nature, sphingolipid enrichment and resulting putative chemoprotective properties, we 
investigated whether diets containing MFGM are protective against colon cancer in Fischer-
344 rats using the aberrant crypt foci (ACF) model. Diets were formulated to differ only in 
the composition of the fat. The control diet contained 5% fat provided as corn oil.  The 
MFGM diet also contained 5% fat, but half of the fat for the MFGM diet was provided as 
anhydrous milk fat and half was provided as MFGM isolate.  MFGM isolate is 
approximately 60% triglycerides and 40% polar lipids.  Besides dietary fat source, both diets 
were identical in macro and micro-nutrients.  Experimental diets were fed for 13 weeks and 
rats were injected with 1,2-dimethylhydrazine (DMH, 25 mg/kg BW) weeks 3 and 4.  After 
13 weeks, rats were euthanized, tissues were collected and ACF were scored by light 
microscopy using the method of (Finley et al. 2001). The Utah State University Institutional 
Animal Care and Use Committee approved all protocols involving animals. 
6.2 Effect of dietary MFGM on appearance of Aberrant Crypt Foci  
The 1,2-dimethylhydrazine induced ACF model is a well established model of colon cancer 
and has been used extensively in nutritional studies (Dillehay et al. 1994; Lemonnier et al. 
2003; Schmelz et al. 2000; Schmelz et al. 1996; Finley et al. 2001; Pretlow et al. 1992; Tudek, 
Bird, and Bruce 1989). Rats fed the MFGM (n=16) diet had a significantly reduced number of 
ACF (P<0.005) compared to the control (n=17) (20.9 ± 5.7 vs. 31.3 ± 9.5) and AMF (n=16) 
diets (29.8 ± 11.4), and ACF was not significantly different between control and AMF 
treatments (Figure 5-A).  Dietary treatment had no effect on ACF size (Figure 5-B) nor was 
there a significant difference in the number of ACF with four or more crypts/focus (data not 
shown) possibly suggesting that MFGM treatment is more relevant to preventing ACF 
initiation as opposed to ACF growth progression.  
 
 
Fig. 5. Effect of experimental diets on (A) 1,2-dimethylhydrazine induced aberrant crypt foci 
(ACF) and (B) ACF size. Values are means (n=17 control diet, n=16 anhydrous milk fat diet, 
n=16 milk fat globular membrane diet) ± standard deviation.  Significant differences were 
determined by ANOVA and Fisher’s LSD test.  Adapted from (Snow et al. 2010)     
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6.3 Effect of dietary MFGM on rat mucosal gene expression 
Out of 21,792 genes, a total of 417, 450, and 321 genes were differentially regulated with 
significance in the mucosa between the MFGM and control, AMF and control, and MFGM 
and AMF dietary treatments, respectively. Despite the observation that MFGM treatment 
decreased ACF compared to both control and AMF; no common gene regulation was 
observed between MFGM vs. control and AMF. 
Although dietary MFGM treatment did not influence the expression of common colon cancer 
genes; sphingomyelin and MFGM’s ability to regulate post-transcriptional gene expression 
cannot be completely ruled out. A recent study demonstrated that sphingomyelin treatment 
did not significantly alter mRNA levels but had a significant effect on protein levels of genes 
critical to the early stages of colon cancer, such as, beta-catenin, connexin-43 and Bcl-2 (Simon 
et al. 2009).  Our results together with these recent findings suggest that the sphingolipids 
present in the MFGM may not be regulating transcription but may be regulating specific post-
transcriptional events to reverse aberrant expression of individual proteins involved in colon 
carcinogenesis.  Because many of the phospholipids found in MFGM are common second 
messengers, future studies utilizing pathway analysis and proteomics to examine any 
relationships between MFGM and relevant metabolic pathways are needed. 
6.4 Summary  
Our results support the hypothesis that diets containing MFGM are protective against colon 
cancer in Fischer-344 rats, perhaps because of MFGM’s high polar lipid content, namely, 
sphingomyelin.  By incorporating MFGM into the diet, animals were provided (0.11% w/w) 
sphingomyelin.  Previous studies using sphingomyelin concentrations ranging from 0.025% 
to 0.1% sphingomyelin (by weight) have clearly shown sphingomyelin’s role in the 
prevention of colon carcinogenesis (Dillehay et al. 1994; Lemonnier et al. 2003; Schmelz et al. 
2000; Simon et al. 2009); however many of those studies used a very pure form of isolated 
sphingomyelin.  In this study, the sphingomyelin is in a more practical form or more similar 
to how it would be incorporated into human diets, and the MFGM contains other important 
phospholipids such as phosphatidylcholine and phosphatidylethanolamine.  One other 
major difference in the MFGM diet, compared to the control and AMF diets, was the 
contribution of MFGM proteins. Several of these membrane proteins have been 
hypothesized to provide biological effects, and we cannot rule out the fact that they may 
have contributed to the protective effect of the diet.  In pilot studies conducted in vitro, we 
noted that these proteins are extensively proteolyzed by a combination of stomach and 
pancreatic proteases, but this does not rule out bioactivity mediated by the peptide 
fragments.  Thus, the contribution of these proteins remains unknown.  The results of this 
study demonstrate that MFGM, a readily available byproduct from dairy processing, can be 
incorporated into diets and is protective against colon cancer. 
7. MFGM and inflammation 
Inflammation causes increased intestinal permeability and gut barrier integrity is 
compromised leading to dysfunction (Zayat, Lichtenberger, and Dial 2008). While the 
mechanism of how gut barrier dysfunction occurs is unclear, pro-inflammatory cytokines, 
such as, IL-4, IL-13, IFN-Ȗ, and TNF-α, have been reported to increase the permeability of 
intestinal epithelia (Fink 2003; Lewis and McKay 2009; Yajima et al. 2009).  Several studies 
suggest that various milk sphingolipids, including sphingomyelin and gangliosides, 
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positively affect the gut by exhibiting a protective effect against colon cancer (Dillehay et al. 
1994; Duan and Nilsson 2009; Nilsson and Duan 2006; Schmelz et al. 1996; Schmelz et al. 
2000), and other studies have linked sphingolipids and other milk fat fractions containing 
phospholipids and gangliosides to the inhibition of a pro-inflammatory response and gut 
barrier protection (Dalbeth et al. 2009; El Alwani et al. 2006; Park et al. 2007; Park et al. 2005; 
Park, Thomson, and Clandinin). 
One source of a variety of dietary sphingolipids is MFGM.  The phospholipids and membrane 
glycoproteins found in MFGM likely interact extensively with the gut epithelia during 
digestion, both physically and biochemically.  Its unique composition has led to the idea that 
MFGM could have remarkable nutraceutical properties (Spitsberg 2005), and various research 
groups are conducting studies to ease its recovery from buttermilk (Astaire et al. 2003; 
Corredig, Roesch, and Dalgleish 2003; Morin et al. 2007; Morin, Jimenez-Flores, and Pouliot 
2006; Morin, Pouliot, and Jimenez-Flores 2006; Rombaut, Dejonckheere, and Dewettinck 2006, 
2007; Rombaut and Dewettinck 2007; Spence et al. 2005; Spence et al. 2009, 2009). 
Although MFGM’s recovery is well documented, very few studies have been conducted to 
determine any nutritional benefits of MFGM, although some indicate beneficial effects of its 
components.  One study demonstrated that milk fat globule–EGF factor-8/lactadherin, a 
major protein component associated with MFGM, is an important factor in maintaining 
epithelial homeostasis and mucosal integrity of the intestinal tract (Bu et al. 2007), and other 
groups have demonstrated the MFGM-derived polar lipids improve the resistance of 
epithelia to stress (Dial and Lichtenberger 1987; Kivinen et al. 1995). 
We investigated whether diets containing MFGM will promote gut mucosal integrity in 
BALB/c mice challenged with lipopolysaccharide (LPS).  LPS induces an inflammatory 
response mimicking gastrointestinal injury (Zayat, Lichtenberger, and Dial 2008), and has 
been used in numerous studies to emulate the inflammatory response seen in gram negative 
bacterial infections.  Because of MFGM’s phospholipid enrichment and unique biochemical 
nature, we hypothesized that diets providing MFGM as a fat source might protect against an 
exaggerated inflammatory response and corresponding compromised gut barrier integrity. 
7.1 Experimental design  
Diets were formulated to differ only in the composition of the fat. The control diet contained 
5% fat provided as corn oil.  The MFGM diet also contained 5% fat, but half of the fat for the 
MFGM diet was provided as anhydrous milk fat and half was provided as MFGM isolate.  
MFGM isolate is approximately 60% triglycerides and 40% polar lipids.  Besides dietary fat 
source, both diets were identical in macro and micro nutrients. The measurement of protein, 
total fat, ash and lactose were conducted as previously described (Spence et al. 2009). Ash 
was further analyzed for specific minerals by inductively coupled plasma spectroscopy 
(ICP-AES) at a core facility on the USU campus.  
To test the hypothesis that MFGM confers protective effects against LPS induced 
inflammation and improves gut barrier protection; a 2 Х 2 factorial design was used. 
Weanling, male BALB/c mice (n=24/time point) were randomly assigned to one of the 
following treatments: 1) control diet (AIN-76A), saline vehicle control injection (n=6); 2) 
control diet, LPS injection (n=6); 3) MFGM diet (AIN-76A with milk fat), saline vehicle 
control injection (n=6); or 4) MFGM diet, LPS injection (n=6) (Figure 6).  Mice were fed 
experimental diets for five weeks.  This timeframe is precedented by a previous 
investigation examining dietary Zn and LPS induced inflammation (Peterson et al. 2008).  
On day 35, Mice were injected intraperitoneally (i.p.) with a dose of saline vehicle control or 
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LPS (10 mg/kg body weight) known to induce inflammatory cytokines and compromise gut 
barrier integrity.  This dose of LPS (i.p.) has previously been shown to induce monocyte 
adhesion and infiltration into intestinal tissues of mice and induce intestinal distress 
(Peterson et al. 2008).  To assess intestinal permeability, mice were gavaged with 4000 Da 
Dextran-FITC (Sigma) suspended in PBS immediately after vehicle control or LPS injection 
(Krimsky et al. 2000).  After injection and gavage, animals were serially harvested at 24 h 
and 48 h by CO2 asphyxiation.  In a preliminary study we saw no changes in the appearance 
of plasma fluorescence after LPS injection at 0 and 12 h with peak fluorescence occurring at 
24 h (data not shown).  These time points and animal numbers have been used successfully 
to determine statistical differences in membrane integrity (Krimsky et al. 2000).  Serum, 
liver, femur, and muscle samples were taken and stored for future analysis.  
To assess gut barrier integrity, serum samples from all time points were assayed for dextran-
FITC (Amersham Typhoon Trio+® and ImageQuant© TL software, GE Healthcare Bio-
Sciences, Uppsala, Sweden). Dextran-FITC permeation of the gut has shown to be a sensitive 
indicator of gut barrier integrity in vivo and serum dextran-FITC levels are positively 
correlated with intestinal insult (Krimsky et al. 2000).   
Serum cytokine analysis was performed on samples from all time points using the Q-Plex™ 
Mouse Cytokine - Screen (16-plex) array (Quansys Biosciences, Logan, UT, USA).  Cytokines 
analyzed include: IL-1α, IL-1ȕ, IL-2, IL-3, IL-4, IL-5, IL-6, IL-10, IL-12p70, IL-17, MCP-1, 
IFNȖ, TNFα, MIP-1α, GMCSF, and RANTES. LPS has been shown to elevate serum 
concentrations of various cytokines in mice, specifically IL-6, IL-10, IL-12, MCP-1, IFNȖ, and 
TNFα (Nandi et al. 2009).  
7.2 Effect of MFGM on gut permeability 
Analysis of dextran-FITC levels in serum showed that gut permeability decreased 
significantly at 24 h in animals fed MFGM diet (MFGM diet/LPS/24h: 5.92 ± 0.59 µg/mL) 
versus control diet (control diet/LPS/24h: 10.8 ± 0.18 µg/mL; P<0.05) when challenged with 
LPS, which is a 45% decrease.  Animals injected with the vehicle control had the same serum  
 
 
Fig. 6. Effect of experimental diets and treatments on gut permeability at 24g.  Serum 
fluorescence levels of LPS challenged mice fed MFGM diet did not differ significantly from 
those receiving vehicle injection but were significantly lower (P<0.05) than LPS challenged 
mice fed control diet at 24 h.  Data are mean dextran-FITC concentrations ± standard 
deviations.  Differently labeled columns are significantly different (P<0.05).  
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fluorescence levels of LPS challenged animals fed the MFGM diet at 24 and 48 h (control 
diet/saline/24h: 6.37 ± 1.29 µg/mL; control diet/saline/48h: 5.63 ± 0.39 µg/mL; MFGM 
diet/saline/24h: 5.80 ± 0.31 µg/mL; MFGM diet/saline/48h: 5.75 ± 0.46 µg/mL; MFGM 
diet/LPS/48h: 5.68 ± 0.55 µg/mL). All animals fed control diet and challenged with LPS 
died before the 48 h time point. Serum fluorescence of animals fed control diet and challenged 
with LPS was significantly higher than animals fed MFGM diet and challenged with LPS, 
illustrating that MFGM plays a role in protecting against gastrointestinal injury.  Also, animals 
fed MFGM diet and challenged with LPS had serum fluorescence levels that did not differ 
significantly from animals fed control and MFGM diets receiving vehicle injections, (Figure 6) 
further demonstrating MFGM’s protective effect on gut barrier integrity. 
 
7.3 Effect of MFGM on serum cytokines 
At the 24 h time point, six of the 16 total cytokines had a significantly lower serum 
concentration among animals fed the MFGM diet versus the control diet.  IL-6 was the most 
significant difference (2.24 pg/mg serum protein ± 0.34 vs. 4.00 pg/mg serum protein ± 0.42; 
P<0.002).  Other serum cytokine concentrations that were significantly lower were IL-10 
(3.12 fg/mg serum protein ± 0.04 vs. 3.61 fg/mg serum protein ± 0.30; P<0.04); IL-17 (2.79 
fg/mg serum protein ± 0.60 vs. 3.71 fg/mg serum protein ± 0.64; P<0.03); MCP-1 (1.90 
pg/mg serum protein ± 0.67 vs. 3.07 pg/mg serum protein ± 0.83; P<0.05); IFNȖ (2.87 fg/mg 
serum protein ± 0.29 vs. 4.13 fg/mg serum protein ± 0.61; P<0.025); TNFα (2.47 fg/mg serum 
protein ± 0.12 vs. 3.21 fg/mg serum protein ± 0.40; P<0.03); and IL-12p70 (2.67 fg/mg serum 
protein ± 0.02 vs. 3.52 fg/mg serum protein ± 0.24; P<0.002).  Serum concentrations of IL-3 
were below the detection limit at 24 h and 48 h.  Serum cytokines did not differ significantly 
in any of the following cytokines at 24 h: IL-1α, IL-1ȕ, IL-5, MIP-1α, GMCSF, and RANTES.  
Cytokines IL-2 and IL-4 were not affected by LPS challenge (For summary see Table 4). 
 
Cytokine Effect of Diet on Serum Cytokine Concentrations 24 hours post 5 mg/kg 
bodyweight LPS Challenge 
GMCSF No difference between control and MFGM dietary treatments 
IL-1α No difference between control and MFGM dietary treatments 
IL1-β No difference between control and MFGM dietary treatments 
IL-3 Below detection limit in MFGM dietary treatment 
IL-5 No difference between control and MFGM dietary treatments 
IL-6 Significantly lower in MFGM dietary treatment compared to control (P <0.005) 
IL-10 Significantly lower in MFGM dietary treatment compared to control (P <0.05) 
IL-12p70 Significantly lower in MFGM dietary treatment compared to control (P <0.005) 
IL-17 Significantly lower in MFGM dietary treatment compared to control (P <0.05) 
INFγ Significantly lower in MFGM dietary treatment compared to control (P <0.05) 
MCP-1 Significantly lower in MFGM dietary treatment compared to control (P <0.05) 
MIP-1 No difference between control and MFGM dietary treatments 
RANTES No difference between control and MFGM dietary treatments 
TNF-α Significantly lower in MFGM dietary treatment compared to control (P <0.05) 
Table 4. Significant effects of dietary treatment on serum cytokine levels after LPS challenge 
at 24h.   
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7.4 Summary 
During inflammation, cytokines are released in response to trauma as represented by the 
control diet with LPS challenge. The decreased serum levels of several cytokines in mice fed 
the experimental diet suggest that MFGM reduces the inflammatory response following 
stress.  Our results are consistent with those investigating the effects of sphingolipids and 
gangliosides on inflammation (Dalbeth et al. 2009; El Alwani et al. 2006; Park et al. 2007; 
Park et al. 2005), suggesting that the high sphingolipid content of MFGM could be 
responsible for the lowered inflammatory response. 
Gut barrier dysfunction has been identified as a result of cytokine induction due to 
inflammation (Sun et al. 1999). As adhesion molecules are expressed on the endothelial 
membrane surface, inflammatory mediators are produced and released which compromise 
gut barrier integrity by interacting with the circulating leukocytes (Formela, Galloway, and 
Kingsnorth 1995).  Our results suggest that MFGM as a dietary component plays a role in 
protecting against intestinal permeability by controlling the inflammatory response, causing 
the gut barrier to remain better intact. 
In conclusion, after treatment with LPS, we saw that MFGM dietary treatment led to a 45% 
decrease in gut permeability and significant differences of serum cytokine levels in eight of 
the 16 cytokines analyzed when compared to control dietary treatment.  Our results imply 
that MFGM, a by-product of dairy processing, is protective against gastrointestinal stress.  
Possible mechanisms for its protection are the increased polar lipid content of the MFGM 
diet and the inhibition of several cytokines during the inflammatory response, leading to 
increased gut barrier integrity.  
8. Conclusion 
MFGM is a complex biopolymer.  It contains various protein and lipid components that 
have been shown to exhibit beneficial properties in the gut.  To date, no other studies have 
examined the effects of dietary MFGM as a whole dietary component on cancer, gut 
permeability and inflammation, contributing to the novelty of these studies.   
The results of these studies support the hypothesis that dietary MFGM protects against 
colon cancer in rats.  Although no differences were seen in candidate carcinogenesis gene 
mRNA levels by microarray analysis, we cannot rule out the suggestion that MFGM affects 
gene regulation.  A recent study demonstrated that sphingomyelin (a major component of 
MFGM) did not alter mRNA levels but had a significant effect on protein levels of genes 
critical to the early stages of colon cancer (Simon et al. 2009).  Animals receiving the MFGM 
dietary treatment were provided with three to four times the amount of sphingomyelin 
compared to animals receiving control or AMF dietary treatments (0.11% vs. 0.03% w/w).  
The high polar lipid content and unique protein profile of MFGM likely contributed to the 
beneficial effects. 
The results of this study also support the hypothesis that dietary MFGM protects against 
gastrointestinal stress in mice and cultured Caco2 cells.  Gut permeability, a common 
condition during gastrointestinal stress, was significantly lower in MFGM treated Caco-2 
cells challenged with EGTA and animals challenged with LPS receiving the MFGM dietary 
treatment compared with those receiving control dietary treatment.  This effect is most 
likely due to the inhibition of the inflammatory response seen in animals receiving the 
MFGM dietary treatment, although the mechanism of how dietary MFGM inhibited the 
inflammatory response is not yet understood.  Many of the polar lipids and proteins found 
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in MFGM have been shown to encourage mucosal integrity, maintain epithelial homeostasis 
and improve the resistance of epithelia to stress; therefore, MFGM’s high polar lipid content 
and unique protein profile likely contribute to its decrease in gut permeability. 
Through the course of these studies, we have demonstrated that MFGM can be incorporated 
into diets.  And, as a dietary component, MFGM plays a role in a protection mechanism 
against colon cancer and gastrointestinal stress. 
9. References 
Adkins, Y., and B. Lonnerdal. 2003. Potential host-defense role of a human milk vitamin B-
12-binding protein, haptocorrin, in the gastrointestinal tract of breastfed infants, as 
assessed with porcine haptocorrin in vitro. Am J Clin Nutr 77 (5):1234-40. 
Affolter, Michael, Laetitia Grass, Frank Vanrobaeys, Begoña Casado, and Martin Kussmann. 
2010. Qualitative and quantitative profiling of the bovine milk fat globule 
membrane proteome. Journal of Proteomics 73 (6):1079-1088. 
Astaire, J. C., R. Ward, J. B. German, and R. Jimenez-Flores. 2003. Concentration of polar 
MFGM lipids from buttermilk by microfiltration and supercritical fluid extraction. 
Journal of Dairy Science 86 (7):2297-2307. 
Bernback, S., L. Blackberg, and O. Hernell. 1990. The complete digestion of human milk 
triacylglycerol in vitro requires gastric lipase, pancreatic colipase-dependent lipase, 
and bile salt-stimulated lipase. J Clin Invest 85 (4):1221-6. 
Blikslager, A. T., M. C. Roberts, and R. A. Argenzio. 1999. Prostaglandin-induced recovery 
of barrier function in porcine ileum is triggered by chloride secretion. Am J Physiol 
276 (1 Pt 1):G28-36. 
Brisson, Guillaume, Hannah F. Payken, John P. Sharpe, and Rafael Jiménez-Flores. 2010. 
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